Manufacturing capacity in 2021 shows a possible limit of 2 billion, even if the possible vaccine was approved in January. But with seven of the nine prototype vaccines in late stage clinical trials requiring two doses, that’s only likely to be enough to immunise a little over 12% of the 7.8 billion people who need it.
Coronavirus: Is there enough manufacturing capacity for the vaccine race whoever is successful?
